SEC Filings | Biora Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
August 6, 2021	EFFECT	EFFECT	Other	View HTML 9999999995-21-003096.pdf 9999999995-21-003096.rtf 9999999995-21-003096.xls
August 4, 2021	CORRESP	CORRESP	Other	View HTML 0001193125-21-236267.pdf 0001193125-21-236267.rtf 0001193125-21-236267.xls
August 3, 2021	UPLOAD	UPLOAD	Other	View HTML 0000000000-21-009522.pdf 0000000000-21-009522.rtf
July 30, 2021	S-3	Simplified registration form	Registration statements	View HTML 0001193125-21-231448.pdf 0001193125-21-231448.rtf 0001193125-21-231448.xls
July 6, 2021	3	Initial filing by director officer or owner of more than ten percent	3,4,5	View HTML 0000899243-21-027612.pdf 0000899243-21-027612.rtf 0000899243-21-027612.xls
July 6, 2021	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000899243-21-027614.pdf 0000899243-21-027614.rtf 0000899243-21-027614.xls
June 30, 2021	8-K	Report of unscheduled material events or corporate event	Current reports	View HTML 0001193125-21-203929.pdf 0001193125-21-203929.rtf 0001193125-21-203929.xls
June 30, 2021	EFFECT	EFFECT	Other	View HTML 9999999995-21-002610.pdf
June 28, 2021	CORRESP	CORRESP	Other	View HTML 0001193125-21-201892.pdf 0001193125-21-201892.rtf 0001193125-21-201892.xls
June 25, 2021	UPLOAD	UPLOAD	Other	View HTML 0000000000-21-007870.pdf 0000000000-21-007870.rtf

Data provided by Kaleidoscope.